These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 24148129)

  • 21. Biodiversity of small molecules--a new perspective in screening set selection.
    Petrone PM; Wassermann AM; Lounkine E; Kutchukian P; Simms B; Jenkins J; Selzer P; Glick M
    Drug Discov Today; 2013 Jul; 18(13-14):674-80. PubMed ID: 23454345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of Iterative Screening with Stepwise Compound Selection Based on Novartis In-house HTS Data.
    Paricharak S; IJzerman AP; Bender A; Nigsch F
    ACS Chem Biol; 2016 May; 11(5):1255-64. PubMed ID: 26878899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification and validation of bioactive small molecule target through phenotypic screening.
    Cho YS; Kwon HJ
    Bioorg Med Chem; 2012 Mar; 20(6):1922-8. PubMed ID: 22153994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening Europe 2010: an update about the latest technologies and applications in high-throughput screening.
    Merten CA
    Expert Rev Mol Diagn; 2010 Jul; 10(5):559-63. PubMed ID: 20629504
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cheminformatic analysis of high-throughput compound screens.
    Backman TW; Girke T
    Methods Mol Biol; 2014; 1056():145-57. PubMed ID: 24306871
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting RNA structures in diseases with small molecules.
    Shao Y; Zhang QC
    Essays Biochem; 2020 Dec; 64(6):955-966. PubMed ID: 33078198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening methods for influenza antiviral drug discovery.
    Atkins C; Evans CW; White EL; Noah JW
    Expert Opin Drug Discov; 2012 May; 7(5):429-38. PubMed ID: 22435452
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Label-free primary screening and affinity ranking of fragment libraries using parallel analysis of protein panels.
    Hämäläinen MD; Zhukov A; Ivarsson M; Fex T; Gottfries J; Karlsson R; Björsne M
    J Biomol Screen; 2008 Mar; 13(3):202-9. PubMed ID: 18270366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-content screening of small compounds on human embryonic stem cells.
    Barbaric I; Gokhale PJ; Andrews PW
    Biochem Soc Trans; 2010 Aug; 38(4):1046-50. PubMed ID: 20659001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Fluorescence-based Lymphocyte Assay Suitable for High-throughput Screening of Small Molecules.
    Fouda A; Tahsini M; Khodayarian F; Al-Nafisah F; Rafei M
    J Vis Exp; 2017 Mar; (121):. PubMed ID: 28362377
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The zebrafish: a powerful platform for in vivo, HTS drug discovery.
    Delvecchio C; Tiefenbach J; Krause HM
    Assay Drug Dev Technol; 2011 Aug; 9(4):354-61. PubMed ID: 21309713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toward high-throughput drug screening on a chip-based parallel affinity separation platform.
    Ohlson S; Duong-Thi MD; Bergström M; Fex T; Hansson L; Pedersen L; Guazotti S; Isaksson R
    J Sep Sci; 2010 Sep; 33(17-18):2575-81. PubMed ID: 20730836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting wall techoic acid biosynthesis: an in vivo based high-throughput screen for small molecule inhibitors.
    Chen W; Woodward R; Wang PG
    ACS Chem Biol; 2009 Nov; 4(11):893-4. PubMed ID: 19888733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Construction and application of a photo-cross-linked chemical array.
    Kondoh Y; Honda K; Osada H
    Methods Mol Biol; 2015; 1263():29-41. PubMed ID: 25618334
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug and bioactive molecule screening based on a bioelectrical impedance cell culture platform.
    Ramasamy S; Bennet D; Kim S
    Int J Nanomedicine; 2014; 9():5789-809. PubMed ID: 25525360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enrichment analysis for discovering biological associations in phenotypic screens.
    Polyakov VR; Moorcroft ND; Drawid A
    J Chem Inf Model; 2014 Feb; 54(2):377-86. PubMed ID: 24437550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA tags help the hunt for drugs.
    Mullard A
    Nature; 2016 Feb; 530(7590):367-9. PubMed ID: 26887498
    [No Abstract]   [Full Text] [Related]  

  • 38. Hypothesis-driven screening.
    Schopfer U; Engeloch C; Höhn F; Mees H; Leeds J; Glickman F; Scheel G; Ferrand S; Fekkes P; Pfeifer M
    Methods Mol Biol; 2009; 575():297-316. PubMed ID: 19727621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Virtual screening of compound libraries.
    Cerqueira NM; Sousa SF; Fernandes PA; Ramos MJ
    Methods Mol Biol; 2009; 572():57-70. PubMed ID: 20694685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Small molecule kinase inhibitor screen identifies polo-like kinase 1 as a target for neuroblastoma tumor-initiating cells.
    Grinshtein N; Datti A; Fujitani M; Uehling D; Prakesch M; Isaac M; Irwin MS; Wrana JL; Al-Awar R; Kaplan DR
    Cancer Res; 2011 Feb; 71(4):1385-95. PubMed ID: 21303981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.